Skip to main content
Riken Vitamin Co., Ltd. logo

Riken Vitamin Co., Ltd. — Investor Relations & Filings

Ticker · 4526 ISIN · JP3972600005 T Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2020-10-15 Audit Report / Informat…
Country JP Japan
Listing T 4526

About Riken Vitamin Co., Ltd.

https://www.rikenvitamin.jp/en/

Riken Vitamin Co., Ltd. develops and manufactures a wide range of products based on its core technologies of extraction, refinement, and concentration, originally established through the commercialization of natural Vitamin A. The company's portfolio includes food ingredients and improvers such as emulsifiers and stabilizers for the processed food industry, as well as natural extracts, seasonings, and vitamins. It also manufactures and sells commercial and consumer food products, including dressings and seaweed-based items. Riken Vitamin leverages its expertise in effectively utilizing natural materials to provide solutions that enhance food quality, safety, and nutritional value for both industrial clients and household consumers.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed with the Kanto Local Finance Bureau regarding the accuracy of a previously filed Annual Securities Report (有価証券報告書). It references the Financial Instruments and Exchange Act and confirms the validity of the 84th fiscal period report. Since it is a regulatory filing confirming the accuracy of a report rather than the report itself or a simple announcement, it falls under the general regulatory filing category. FY 2020
2020-10-15 Japanese
訂正有価証券報告書－第84期(平成31年4月1日－令和2年3月31日)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (訂正有価証券報告書) for an Annual Securities Report (有価証券報告書). It explicitly references the Financial Instruments and Exchange Act (金融商品取引法) and provides the fiscal year (第84期) and company details. In the Japanese regulatory context, an '有価証券報告書' is the equivalent of a 10-K. Since this is a correction to that filing, it falls under the 10-K category as it pertains to the annual reporting cycle. FY 2020
2020-10-15 Japanese
内部統制報告書－第84期(平成31年4月1日－令和2年3月31日)
Regulatory Filings Classification · 95% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This is a specific regulatory filing required in Japan to report on the effectiveness of internal controls over financial reporting. It is not an annual report (10-K), audit report (AR), or management report (MDA) in the standard sense, but rather a specific regulatory compliance document. Given the provided categories, 'Regulatory Filings' (RNS) is the most appropriate fallback category for this type of specialized regulatory disclosure.
2020-09-30 Japanese
有価証券報告書－第84期(平成31年4月1日－令和2年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. It explicitly states the fiscal year (第84期, 2019-04-01 to 2020-03-31) and is filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. This is the standard Japanese equivalent of a 10-K annual report, containing comprehensive financial statements and business disclosures. FY 2020
2020-09-30 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references the Financial Instruments and Exchange Act (金融商品取引法). It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2020
2020-09-30 Japanese
訂正四半期報告書－第84期第3四半期(令和1年10月1日－令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Riken Vitamin Co., Ltd., covering the third quarter of the 84th fiscal year (April 1, 2019, to December 31, 2019). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis and notes. Although the title mentions 'Correction' (訂正), it is a comprehensive financial report for an interim period, not merely an announcement or a certification. Therefore, it is classified as an Interim/Quarterly Report. 9M 2020
2020-09-30 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.